Cargando…
A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model
Intrahepatic cholangiocarcinoma (ICC), a malignant tumor derived from the intrahepatic bile duct epithelium, has a poor prognosis and is refractory to conventional chemotherapy and radiation therapy. Thus, there is an urgent need to develop new effective therapeutic strategies for this disease. We p...
Autores principales: | Lee, Eung Suk, Jeong, Mun Sik, Singh, Rohit, Jung, Juyeon, Yoon, Hyunho, Min, Jeong-Ki, Kim, Kyung Hyun, Hong, Hyo Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349911/ https://www.ncbi.nlm.nih.gov/pubmed/22248567 http://dx.doi.org/10.3858/emm.2012.44.4.027 |
Ejemplares similares
-
Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma
por: Cho, Seulki, et al.
Publicado: (2017) -
Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020) -
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016) -
Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020) -
Primary hepatic tuberculosis mimicking intrahepatic cholangiocarcinoma: report of two cases
por: Park, Jeong-Ik
Publicado: (2015)